[Whitepaper] Medical Affairs 2025 Excellence in the Era of Precision Medicine

Hear from AstraZeneca, Bristol-Myers Squibb, Merck, Lilly & other leading companies

In the era of precision medicine, we see a fundamental shift toward transparency, collaboration, and a more patient-centric model.

Access the report now to gain executive-level insights on:

  • Building new scientific relationships beyond traditional stakeholders
  • Mining actionable insights from expanding data sources
  • The evolving role of artificial intelligence
  • Leading the charge on patient centricity and engagement

Sponsored by: